<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction Schema extraction-schema-2 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extraction Schema Details for extraction-schema-2</h1>

        <div class="section">
            <h2>Extraction Schema (General Information)</h2>
            <div class="info-section">
                <p><strong>Schema ID:</strong> extraction-schema-2</p>
                <p><strong>Extraction Query:</strong> Extract any mentions of specific cell types showing susceptibility or resilience to Alzheimer's disease pathology, including quantitative measures of vulnerability and mechanistic explanations for differential vulnerability.</p>
            </div>
        </div>

        <div class="section">
            <h2>Extraction Schema (Details)</h2>
            <table>
                <thead>
                    <tr>
                        <th style="width: 20%;">Field Name</th>
                        <th style="width: 15%;">Type</th>
                        <th style="width: 65%;">Description</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>cell_type</strong></td>
                        <td>str</td>
                        <td>The specific cell type or cell subtype mentioned (e.g. 'layer V pyramidal neurons', 'CA1 hippocampal neurons', 'microglia', 'oligodendrocytes', 'parvalbumin-positive interneurons', etc.). Be as specific as possible.</td>
                    </tr>
                    <tr>
                        <td><strong>cell_type_description</strong></td>
                        <td>str</td>
                        <td>A brief description of the cell type, including any relevant markers, location, or functional properties mentioned.</td>
                    </tr>
                    <tr>
                        <td><strong>susceptibility_classification</strong></td>
                        <td>str</td>
                        <td>Is this cell type described as susceptible/vulnerable, resilient/resistant, or having intermediate vulnerability to AD pathology? (e.g. 'highly susceptible', 'resilient', 'moderately vulnerable', 'resistant', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>brain_region</strong></td>
                        <td>str</td>
                        <td>Which brain region(s) were these cells studied in? (e.g. 'entorhinal cortex', 'hippocampus CA1', 'prefrontal cortex', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>disease_stage</strong></td>
                        <td>str</td>
                        <td>At what stage of Alzheimer's disease was this observation made? (e.g. 'early stage', 'late stage', 'preclinical', 'mild cognitive impairment', 'across all stages', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>quantitative_measure</strong></td>
                        <td>str</td>
                        <td>Any quantitative measures of cell loss, dysfunction, or survival reported for this cell type (e.g. '60% cell loss', 'reduced by 2.5-fold', 'no significant change', etc.). Include units and comparisons to control if available.</td>
                    </tr>
                    <tr>
                        <td><strong>pathology_exposure</strong></td>
                        <td>str</td>
                        <td>What specific Alzheimer's pathology was this cell type exposed to or associated with? (e.g. 'amyloid-beta plaques', 'tau tangles', 'neuroinflammation', 'oxidative stress', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>mechanism_of_susceptibility</strong></td>
                        <td>str</td>
                        <td>What mechanisms or cellular/molecular features are proposed to explain why this cell type is susceptible to AD? (e.g. 'high metabolic demand', 'low calcium buffering', 'specific receptor expression', 'lack of protective proteins', etc.). Be detailed and specific.</td>
                    </tr>
                    <tr>
                        <td><strong>mechanism_of_resilience</strong></td>
                        <td>str</td>
                        <td>What mechanisms or cellular/molecular features are proposed to explain why this cell type is resilient to AD? (e.g. 'high antioxidant capacity', 'efficient protein clearance', 'protective gene expression', 'low connectivity burden', etc.). Be detailed and specific.</td>
                    </tr>
                    <tr>
                        <td><strong>molecular_features</strong></td>
                        <td>str</td>
                        <td>What specific molecular features, gene expression patterns, or protein markers are associated with this cell type's vulnerability or resilience? (e.g. 'high expression of ApoE4', 'low expression of chaperone proteins', 'presence of specific calcium channels', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>comparison_to_other_cells</strong></td>
                        <td>str</td>
                        <td>If the paper compares this cell type to other cell types, what are the key comparative findings? (e.g. 'more vulnerable than interneurons', 'shows 3x greater loss than glial cells', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>methodology</strong></td>
                        <td>str</td>
                        <td>What methods were used to assess cell type vulnerability or resilience? (e.g. 'single-cell RNA-seq', 'immunohistochemistry', 'stereological cell counting', 'in vitro toxicity assays', 'mouse models', 'human postmortem tissue', etc.)</td>
                    </tr>
                </tbody>
            </table>
        </div>

    </div>
</body>
</html>